Extravascular lung water levels are associated with mortality: a systematic review and meta-analysis.
Critically ill patients
Hemodynamic monitoring
Lung edema
Transpulmonary thermodilution
Journal
Critical care (London, England)
ISSN: 1466-609X
Titre abrégé: Crit Care
Pays: England
ID NLM: 9801902
Informations de publication
Date de publication:
06 07 2022
06 07 2022
Historique:
received:
15
01
2022
accepted:
17
05
2022
entrez:
6
7
2022
pubmed:
7
7
2022
medline:
9
7
2022
Statut:
epublish
Résumé
The prognostic value of extravascular lung water (EVLW) measured by transpulmonary thermodilution (TPTD) in critically ill patients is debated. We performed a systematic review and meta-analysis of studies assessing the effects of TPTD-estimated EVLW on mortality in critically ill patients. Cohort studies published in English from Embase, MEDLINE, and the Cochrane Database of Systematic Reviews from 1960 to 1 June 2021 were systematically searched. From eligible studies, the values of the odds ratio (OR) of EVLW as a risk factor for mortality, and the value of EVLW in survivors and non-survivors were extracted. Pooled OR were calculated from available studies. Mean differences and standard deviation of the EVLW between survivors and non-survivors were calculated. A random effects model was computed on the weighted mean differences across the two groups to estimate the pooled size effect. Subgroup analyses were performed to explore the possible sources of heterogeneity. Of the 18 studies included (1296 patients), OR could be extracted from 11 studies including 905 patients (464 survivors vs. 441 non-survivors), and 17 studies reported EVLW values of survivors and non-survivors, including 1246 patients (680 survivors vs. 566 non-survivors). The pooled OR of EVLW for mortality from eleven studies was 1.69 (95% confidence interval (CI) [1.22; 2.34], p < 0.0015). EVLW was significantly lower in survivors than non-survivors, with a mean difference of -4.97 mL/kg (95% CI [-6.54; -3.41], p < 0.001). The results regarding OR and mean differences were consistent in subgroup analyses. The value of EVLW measured by TPTD is associated with mortality in critically ill patients and is significantly higher in non-survivors than in survivors. This finding may also be interpreted as an indirect confirmation of the reliability of TPTD for estimating EVLW at the bedside. Nevertheless, our results should be considered cautiously due to the high risk of bias of many studies included in the meta-analysis and the low rating of certainty of evidence. Trial registration the study protocol was prospectively registered on PROSPERO: CRD42019126985.
Sections du résumé
BACKGROUND
The prognostic value of extravascular lung water (EVLW) measured by transpulmonary thermodilution (TPTD) in critically ill patients is debated. We performed a systematic review and meta-analysis of studies assessing the effects of TPTD-estimated EVLW on mortality in critically ill patients.
METHODS
Cohort studies published in English from Embase, MEDLINE, and the Cochrane Database of Systematic Reviews from 1960 to 1 June 2021 were systematically searched. From eligible studies, the values of the odds ratio (OR) of EVLW as a risk factor for mortality, and the value of EVLW in survivors and non-survivors were extracted. Pooled OR were calculated from available studies. Mean differences and standard deviation of the EVLW between survivors and non-survivors were calculated. A random effects model was computed on the weighted mean differences across the two groups to estimate the pooled size effect. Subgroup analyses were performed to explore the possible sources of heterogeneity.
RESULTS
Of the 18 studies included (1296 patients), OR could be extracted from 11 studies including 905 patients (464 survivors vs. 441 non-survivors), and 17 studies reported EVLW values of survivors and non-survivors, including 1246 patients (680 survivors vs. 566 non-survivors). The pooled OR of EVLW for mortality from eleven studies was 1.69 (95% confidence interval (CI) [1.22; 2.34], p < 0.0015). EVLW was significantly lower in survivors than non-survivors, with a mean difference of -4.97 mL/kg (95% CI [-6.54; -3.41], p < 0.001). The results regarding OR and mean differences were consistent in subgroup analyses.
CONCLUSIONS
The value of EVLW measured by TPTD is associated with mortality in critically ill patients and is significantly higher in non-survivors than in survivors. This finding may also be interpreted as an indirect confirmation of the reliability of TPTD for estimating EVLW at the bedside. Nevertheless, our results should be considered cautiously due to the high risk of bias of many studies included in the meta-analysis and the low rating of certainty of evidence. Trial registration the study protocol was prospectively registered on PROSPERO: CRD42019126985.
Identifiants
pubmed: 35794612
doi: 10.1186/s13054-022-04061-6
pii: 10.1186/s13054-022-04061-6
pmc: PMC9258010
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
202Informations de copyright
© 2022. The Author(s).
Références
J Clin Epidemiol. 2005 Sep;58(9):882-93
pubmed: 16085191
Crit Care. 2013 Jan 24;17(1):108
pubmed: 23347799
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Anaesthesiol Intensive Ther. 2021;53(1):10-17
pubmed: 33625819
JAMA. 2018 Jul 17;320(3):305
pubmed: 30027240
Chest. 2002 Dec;122(6):2080-6
pubmed: 12475851
PLoS One. 2014 Aug 05;9(8):e103854
pubmed: 25093821
Anaesth Intensive Care. 1999 Aug;27(4):357-62
pubmed: 10470388
Crit Care Med. 2013 Feb;41(2):472-80
pubmed: 23263578
Crit Care. 2010;14(5):R162
pubmed: 20819213
Anaesthesiol Intensive Ther. 2015;47(5):501-16
pubmed: 26578395
Crit Care Med. 2006 Jun;34(6):1647-53
pubmed: 16625129
Ann Intensive Care. 2013 Aug 11;3(1):25
pubmed: 23937970
Anaesthesiol Intensive Ther. 2015;47(5):487-500
pubmed: 26578399
Intensive Care Med. 2002 Apr;28(4):414-8
pubmed: 11967594
Crit Care Med. 2014 Aug;42(8):1869-73
pubmed: 24717463
BMC Pulm Med. 2015 Aug 23;15:98
pubmed: 26298866
Crit Care Med. 2008 Jan;36(1):69-73
pubmed: 18090369
Curr Opin Crit Care. 2018 Jun;24(3):209-215
pubmed: 29608455
Ann Intensive Care. 2020 Mar 2;10(1):28
pubmed: 32124129
Ann Intensive Care. 2015 Dec;5(1):38
pubmed: 26546321
Anaesthesia. 2012 Mar;67(3):236-43
pubmed: 22321078
Crit Care Med. 2014 Aug;42(8):1882-9
pubmed: 24717458
Crit Care. 2011 Aug 27;15(4):R204
pubmed: 21871112
Intensive Care Med. 2016 Sep;42(9):1350-9
pubmed: 27155605
Hemodial Int. 2007 Apr;11(2):231-7
pubmed: 17403176
Crit Care. 2021 Jun 1;25(1):186
pubmed: 34074313
Pharm Stat. 2018 Jul;17(4):317-328
pubmed: 29635777
Ann Intensive Care. 2014 Aug 13;4:27
pubmed: 25593743
J Clin Med. 2019 Jun 11;8(6):
pubmed: 31212621
J Crit Care. 2012 Aug;27(4):420.e1-8
pubmed: 22137377
Intensive Care Med. 2014 Dec;40(12):1795-815
pubmed: 25392034
Crit Care Med. 2013 Sep;41(9):2144-50
pubmed: 23760152
J Formos Med Assoc. 2020 May;119(5):950-956
pubmed: 31822372
J Clin Epidemiol. 2020 May;121:62-70
pubmed: 31982539
J Crit Care. 2012 Aug;27(4):376-83
pubmed: 22591571
Ann Am Thorac Soc. 2017 Jun;14(6):844-850
pubmed: 28570160
Crit Care. 2013 Jun 20;17(4):R132
pubmed: 23844662
Crit Care. 2017 Jun 19;21(1):147
pubmed: 28625165
Ann Intern Med. 2013 Feb 19;158(4):280-6
pubmed: 23420236
Stat Med. 2004 May 15;23(9):1351-75
pubmed: 15116347
Crit Care. 2005 Apr;9(2):R74-82
pubmed: 15774053
Anaesthesiol Intensive Ther. 2015;47(2):89-116
pubmed: 25421923
Respir Med. 2008 Jul;102(7):956-61
pubmed: 18397821
Chest. 2016 May;149(5):1155-64
pubmed: 26896701
Crit Care. 2012 Jan 03;16(1):R1
pubmed: 22214612
Ann Intensive Care. 2012 Jul 05;2(Suppl 1 Diagnosis and management of intra-abdominal hyperten):S1
pubmed: 22873410
PLoS One. 2020 May 6;15(5):e0232720
pubmed: 32374755
Crit Care Med. 2010 Jan;38(1):114-20
pubmed: 19789451
J Crit Care. 2016 Jun;33:106-13
pubmed: 27021852
PLoS One. 2010 Dec 16;5(12):e15265
pubmed: 21187890